French Pharmaceuticals & Biotech Mid-Large Cap Stocks

Sanofi

Market Cap: €92.3b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

DBV Technologies

Market Cap: €941.6m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Sartorius Stedim Biotech

Market Cap: €16.6b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Eurofins Scientific

Market Cap: €11.0b

Provides various analytical testing and laboratory services worldwide.

MedinCell

Market Cap: €975.9m

A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.

Ipsen

Market Cap: €13.2b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

Virbac

Market Cap: €3.0b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

ABIVAX Société Anonyme

Market Cap: €8.4b

A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Nanobiotix

Market Cap: €1.8b

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Inventiva

Market Cap: €909.8m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.